Related Experiment Video
Updated: Jul 31, 2025

Isolating and Analyzing Cells of the Pancreas Mesenchyme by Flow Cytometry
Published on: January 28, 2017
Differentiation of Pancreatic Beta Cells: Dual Acting of Inflammatory Factors
Faeze Shahedi1, Arron Munggela Foma1, Azam Mahmoudi-Aznaveh2
1Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:
In the past decades, scientists have made outstanding efforts to treat diabetes. However, diabetes treatment is still far from satisfactory due to the complex nature of the disease and the challenges encountered in resolving it. Inflammatory factors are key regulators of the immune system's response to pathological insults, organ neogenesis, rejuvenation of novel cells to replace injured cells and overwhelming disease conditions. Currently, the available treatments for type 1 diabetes include daily insulin injection, pancreatic beta cell or tissue transplantation, and gene therapy. Cell therapy, exploiting differentiation, and reprogramming various types of cells to generate pancreatic insulin-producing cells are novel approaches for the treatment of type 1 diabetes. A better understanding of the inflammatory pathways offers valuable and improved therapeutic options to provide more advanced and better treatments for diabetes. In this review, we investigated different types of inflammatory factors that participate in the pathogenesis of type 1 diabetes, their possible dual impacts on the differentiation, reprogramming, and fusion of other stem cell lines into pancreatic insulin-producing beta cells, and the possibility of applying these factors to improve the treatment of this disease.
Insights
Scientists are exploring inflammatory factors to improve type 1 diabetes treatment. Understanding these factors
Area of Science:
- Immunology and Endocrinology: Focuses on the intricate interplay between inflammatory pathways and pancreatic beta cell regeneration for diabetes mellitus treatment.
Background:
- Diabetes mellitus remains a significant health challenge, with current treatments like insulin therapy and transplantation having limitations.
- Inflammatory factors play a critical role in immune responses, tissue repair, and disease progression, impacting diabetes pathogenesis.
- Existing type 1 diabetes (T1D) treatments include insulin injections, pancreatic cell transplantation, and gene therapy, but novel approaches are needed.
Purpose of the Study:
- To review the role of inflammatory factors in the pathogenesis of type 1 diabetes.
- To investigate the dual effects of these factors on stem cell differentiation, reprogramming, and fusion into insulin-producing beta cells.
- To explore the therapeutic potential of manipulating inflammatory pathways for improved T1D treatment.
Main Methods:
- Comprehensive literature review of studies on inflammatory factors and type 1 diabetes.
- Analysis of research on stem cell biology, including differentiation, reprogramming, and fusion processes.
- Examination of the impact of specific inflammatory mediators on pancreatic beta cell generation and function.
Main Results:
- Inflammatory factors exhibit complex, often dual roles in the development and progression of type 1 diabetes.
- These factors can influence the efficiency and success of generating insulin-producing beta cells from various stem cell sources.
- Specific inflammatory pathways present potential targets for novel therapeutic strategies in T1D.
Conclusions:
- A deeper understanding of inflammatory factor mechanisms is crucial for advancing type 1 diabetes therapies.
- Targeting inflammatory pathways may offer a promising avenue for cell-based regenerative approaches to T1D.
- Further research into the precise modulation of these factors could lead to more effective treatments for diabetes mellitus.
More Related Videos
08:41Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
Published on: June 23, 2023
07:44Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
Published on: August 7, 2015
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Insulin Secretory Vesicles
Tissue Renewal without Stem Cells
However, failure of such a system...